EPM
MRTX

Equitec Proprietary Markets’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Equitec Proprietary Markets’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,100
Closed -$2.06M – 128
2023
Q4 		$2.06M Buy
+35,100
New +$1.97M 1.53% 15

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Equitec Proprietary Markets's MRTX Position: Q1 2024 in Review

Equitec Proprietary Markets sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 35,100 shares — an estimated $2.06M sold.

Equitec Proprietary Markets first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.06M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Equitec Proprietary Markets reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Equitec Proprietary Markets sold 35,100 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.06M.
  • Equitec Proprietary Markets first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Equitec Proprietary Markets's Mirati Therapeutics, Inc. Common Stock position peaked at $2.06M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Equitec Proprietary Markets's 13F filing for Q1 2024, filed 26 Apr 2024.